Eleftherios Markatis

HPR197 The Disease Burden of Respiratory Syncytial Virus Among the Adult Population in Greece

Argyro Solakidi, Eleftherios Markatis, C. Tzanetakos, George Gourzoulidis

gr (code pays fourni par la source)

Burden of respiratory syncytial virus disease in infants and the potential value of maternal immunization in Greece

George Gourzoulidis, Argyro Solakidi, Eleftherios Markatis, Marios Detsis et autres

Objective: The objective was to assess the burden of respiratory syncytial virus (RSV) and evaluate the cost-effectiveness of maternal vaccination using the bivalent RSV prefusion F-protein (RSVpreF) vaccine to prevent RSV infections among Greek infants. Methods: A Markov model was adapted from …

gr, gb (code pays fourni par la source)

EE61 Burden of Respiratory Syncytial Virus Disease in Infants and the Potential Value of Maternal Immunization in Greece

A. Solakidi, Myrto Barmpouni, M Psarra, Marios Detsis et autres

EE62 The Value of Vaccination in Prevention of Respiratory Syncytial Virus Disease in Older Adults: A Modelling Analysis for Greece

A. Solakidi, Myrto Barmpouni, Marios Detsis, Eleftherios Markatis et autres

Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Among Older Adults in Greece

George Gourzoulidis, C. Tzanetakos, Argyro Solakidi, Eleftherios Markatis et autres

BACKGROUND/OBJECTIVES: To evaluate the health benefits, costs, and cost-effectiveness of vaccination with bivalent respiratory syncytial virus stabilized prefusion F vaccine (RSVpreF) for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV) in Greek adults 60 years of age …

gb (code pays fourni par la source)

Comparison of RSV, influenza and COVID-19 clinical characteristics in hospitalized adults in Valladolid–Spain, 2010–2022

Mariana Haeberer, Rong Fan, Margarita Asensio, Alejandro Martín Toribio et autres

Introduction: We aimed to describe the clinical characteristics of all laboratory-confirmed Respiratory Syncytial Virus (RSV) cases among adults aged ≥60 years in Valladolid during Jan2010–Aug2022 and to compare them with influenza and COVID-19 controls Methods: Retrospective cohort. We identified risk factors for …

es, us, ie (code pays fourni par la source)

Testing for respiratory syncytial virus (RSV) in Greek adults hospitalized with community-acquired pneumonia (CAP)

Paraskevi Κatsaounou, Adamantia Liapikou, Vasiliki Kossyvaki, John Skiadas et autres

Background: RSV, with the increasing use of molecular tests, has been recognized as a significant cause of adult respiratory infections. Aims and objectives: EGNATIA study aimed to assess RSV prevalence in adult hospitalized CAP. Methods: EGNATIA is a 6-year, prospective study of …

gr, kw, es, us (code pays fourni par la source)

Comorbidity-based distribution of pneumococcal serotypes in Greek adults hospitalized with community-acquired pneumonia (CAP)

Adamantia Liapikou, Vasiliki Kossyvaki, John Skiadas, Eleftherios Markatis et autres

Background: Patients with comorbidities are at increased risk of pneumococcal disease and are often recommended for pneumococcal vaccination. In Greece, since 2015 the 13-valent pneumococcal conjugate vaccine (PCV13) is recommended sequentially with the 23-valent vaccine (PPV23) for adults aged ≥65 years and …

gr, es, us (code pays fourni par la source)

Predictors of Mortality in Tocilizumab-Treated Severe COVID-19

Konstantinos Pagkratis, Serafeim Chrysikos, Emmanouil Antonakis, Aggeliki Pandi et autres

Purpose: Tocilizumab is associated with positive outcomes in severe COVID-19. We wanted to describe the characteristics of nonresponders to treatment. Methods: This was a retrospective multicenter study in two respiratory departments investigating adverse outcomes at 90 days from diagnosis in subjects treated …

gr (code pays fourni par la source)

Predictors of mortality in tocilizumab treated severe Covid-19

Konstantinos Pagkratis, Serafeim Chrysikos, Emmanouil Antonakis, Aggeliki Pandi et autres

gr, kw (code pays fourni par la source)

Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study

Karolina Akinosoglou, Christos Savopoulos, Abraham Pouliakis, Charalampos Triantafyllidis et autres

(1) Background: It is well-established that coronavirus disease-2019 (COVID-19) is highly pro-inflammatory, leading to activation of the coagulation cascade. COVID-19-induced hypercoagulability is associated with adverse outcomes and mortality. Current guidelines recommend that hospitalized COVID-19 patients should receive pharmacological prophylaxis against venous thromboembolism …

gr (code pays fourni par la source)

Mortality Among Hospitalized Patients With Pleural Effusions. A Multicenter, Observational, Prospective Study

Eleftherios Markatis, Garyfallia Perlepe, Andreas Afthinos, Konstantinos Pagkratis et autres

Background Data regarding the prognostic significance of pleural effusion (PE) are scarce. Objective Explore the impact of PE on mortality among hospitalized patients. Methods Multicenter prospective observational study. Patients that underwent computed tomography (thorax and/or abdomen) and in which PE was detected, …

gr (code pays fourni par la source)